ToolGen Incorporated Logo

ToolGen Incorporated

A biotech firm licensing genome editing patents for therapeutics and agriculture.

199800 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크,8층, 강서구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. A pioneer in the field since 1999, the company has developed three successive generations of gene editing tools: Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen holds foundational patents for CRISPR-Cas9 technology, claiming to be the first to file a patent for its use in eukaryotic cells. The company's business model is centered on three core areas: monetizing its intellectual property through licensing and collaboration, developing proprietary therapeutic programs in gene and cell therapy, and applying its technology to improve agricultural crops.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ToolGen Incorporated and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ToolGen Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ToolGen Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan 190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden CHOSA
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan 4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan 7379
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom CIZ
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan 7059
A creator agency connecting professionals in creative, tech, medical, and legal sectors.
Japan 4763
Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.
South Korea 040350
CRG HOLDINGS CO.,LTD. Logo
Provides IT-driven HR services, outsourcing, system solutions, and financial advisory.
Japan 7041
CRONEX.CO.,LTD Logo
CRO supplying mini-pigs and bio-tissues for non-clinical R&D in medical and cosmetic industries.
South Korea 215570

Talk to a Data Expert

Have a question? We'll get back to you promptly.